Safety-Related Labeling Changes

Strong or moderate CYP 3A4 inhibitors, and CYP 3A4 inducers

Trade Name

Reagila

Updated Section

4.5. Interaction with other medicinal products and other forms of interaction

Month

Sep, 2025